February 26, 2024

Medical Trend

Medical News and Medical Resources

Walgreens loses $54 million contract to stop selling abortion drug

Walgreens loses $54 million contract to stop selling abortion drug



 

Walgreens loses $54 million contract to stop selling abortion drug.

Pharmacy Chain Walgreens May Lose Millions After Suspending Abortion Drug Shipments.

 

The recent decision by pharmacy chain Walgreens to suspend the shipment of the abortion drug “mifepristone” to 20 conservative states has triggered a backlash.

California Governor Gavin Newsom announced that the state government will not renew its $54 million contract with Walgreens for the purchase of prescription drugs for the California state prison system. Newsom expressed concern over Walgreens’ decision and dissatisfaction with the suspension of the abortion drug.

 

 

 

According to the San Francisco Chronicle, the contract was scheduled to be renewed on May 1 and was paid out over eight years, with $11.5 million paid out last year.

Walgreens’ decision not to mail one of the two abortion pills to the 20 conservative states led to the company becoming a political target of both parties. The decision has now cost Walgreens a significant business contract.

 

Governor Newsom’s statement on social media indicated that the state will not do business with corporations that bow to extremists and cut off vital access and freedoms to maternity care. California will use its market power to defend the right of choice.

 

Walgreens responded with a statement, saying that once it obtains federal approval, it will distribute “mifepristone” in any jurisdiction where it can legally do so.

However, no details were given on when this would occur.

Republican state attorneys general have argued that an 1873 federal law effectively bans the mailing of abortion-inducing drugs anywhere in the United States, but the Justice Department disagrees.

 

The decision by Walgreens highlights the importance of access to abortion care and the need for corporations to prioritize the health and well-being of their customers. It also emphasizes the role of states in defending the right to choose and promoting access to necessary medical care.

 

Mifeprime is one of two drugs currently used for most abortions in the United States.

Abortion advocates have warned that restricting access to the drug could seriously deter American women from obtaining abortions.

 

 

Walgreens loses $54 million contract to stop selling abortion drug

(source:internet, reference only)


Disclaimer of medicaltrend.org


Important Note: The information provided is for informational purposes only and should not be considered as medical advice.